HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giuseppe La Torre Selected Research

Breast Neoplasms (Breast Cancer)

1/2017IORT in breast cancer. Our experience of the first patients treated.
10/2013Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1.
5/2010Use of trastuzumab in HER2-positive metastatic breast cancer beyond disease progression: a systematic review of published studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giuseppe La Torre Research Topics

Disease

11Neoplasms (Cancer)
05/2019 - 03/2007
8COVID-19
09/2023 - 01/2020
8Stomach Neoplasms (Stomach Cancer)
05/2019 - 01/2005
7Infections
01/2022 - 08/2005
6Myocardial Infarction
01/2018 - 05/2007
6Inflammation (Inflammations)
01/2017 - 03/2009
5Rectal Neoplasms (Rectal Cancer)
11/2020 - 02/2008
4Stroke (Strokes)
06/2022 - 09/2012
4Pain (Aches)
02/2019 - 05/2012
4Hypertension (High Blood Pressure)
01/2018 - 07/2012
4Non-alcoholic Fatty Liver Disease
06/2016 - 06/2009
3Human Influenza (Influenza)
08/2022 - 02/2013
3Neoplasm Metastasis (Metastasis)
01/2019 - 09/2008
3Cardiovascular Diseases (Cardiovascular Disease)
06/2018 - 06/2013
3Breast Neoplasms (Breast Cancer)
01/2017 - 05/2010
3Ulnar Neuropathies (Ulnar Neuropathy)
11/2016 - 02/2011
3Thrombosis (Thrombus)
07/2014 - 06/2009
3Disease Progression
05/2010 - 03/2009
2Prostatic Neoplasms (Prostate Cancer)
08/2023 - 04/2015
2Rubella (German Measles)
09/2022 - 01/2017
2Measles
09/2022 - 01/2017
2Retinal Vein Occlusion
09/2022 - 09/2017
2Virus Diseases (Viral Diseases)
01/2020 - 01/2017
2Wounds and Injuries (Trauma)
01/2019 - 01/2019
2Pathologic Complete Response
01/2019 - 09/2008
2Chronic Disease (Chronic Diseases)
01/2017 - 09/2015
2Chronic Obstructive Pulmonary Disease (COPD)
09/2015 - 11/2012
2Heart Failure
09/2015 - 06/2013
2Adenocarcinoma
12/2013 - 11/2005
2ST Elevation Myocardial Infarction
06/2013 - 03/2009
2Atrial Fibrillation
08/2011 - 01/2009
2Glioblastoma (Glioblastoma Multiforme)
01/2011 - 12/2007
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2010 - 04/2009
2Carcinoma (Carcinomatosis)
02/2008 - 03/2005
1Fatigue
09/2023
1Asthenia
09/2023
1Headache (Headaches)
09/2023
1Myalgia
09/2023
1Fever (Fevers)
09/2023
1Nausea
09/2023
1Sleep Wake Disorders
01/2023
1Chickenpox
09/2022
1Lymphoma (Lymphomas)
01/2022
1Thyroid Diseases (Thyroid Disease)
01/2022
1Heart Diseases (Heart Disease)
01/2022
1Rheumatoid Arthritis
01/2021
1Synovitis
01/2021
1Joint Diseases (Joint Disease)
01/2021
1Multiple Sclerosis
01/2021
1Occupational Stress
01/2020

Drug/Important Bio-Agent (IBA)

10VaccinesIBA
09/2023 - 04/2010
5SmokeIBA
01/2022 - 11/2007
4CholesterolIBA
01/2022 - 01/2008
3Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2005
3Proteins (Proteins, Gene)FDA Link
05/2019 - 10/2013
3Glucose (Dextrose)FDA LinkGeneric
01/2015 - 01/2008
3Monoclonal AntibodiesIBA
01/2014 - 03/2008
2Influenza Vaccines (Influenza Vaccine)FDA Link
01/2023 - 08/2022
2Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
01/2022 - 07/2008
2LipidsIBA
01/2022 - 07/2010
2Messenger RNA (mRNA)IBA
05/2019 - 09/2008
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019 - 02/2008
2SodiumIBA
03/2017 - 07/2014
2Anti-Bacterial Agents (Antibiotics)IBA
01/2017 - 12/2008
2C-Reactive ProteinIBA
08/2011 - 01/2008
2NestinIBA
01/2011 - 12/2007
2Interleukin-6 (Interleukin 6)IBA
03/2009 - 08/2005
2histidylhistidine (His-His)IBA
11/2007 - 11/2005
2SulfotransferasesIBA
07/2006 - 11/2005
1Acetaminophen (Paracetamol)FDA LinkGeneric
09/2023
1mRNA VaccinesIBA
09/2023
1Prostate-Specific Antigen (Semenogelase)IBA
08/2023
1Contrast MediaIBA
08/2023
1AntibodiesIBA
09/2022
1Retinaldehyde (Retinal)IBA
09/2022
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2022
1AnticoagulantsIBA
01/2022
1oxidized low density lipoproteinIBA
01/2022
1Hormones (Hormone)IBA
01/2022
1Amiodarone (Amiodarona)FDA LinkGeneric
01/2022
1Verapamil (Calan)FDA LinkGeneric
01/2022
1Ion Channels (Ion Channel)IBA
01/2022
1sirioIBA
01/2022

Therapy/Procedure

19Therapeutics
09/2023 - 03/2008
5Radiotherapy
01/2017 - 02/2008
4Chemoradiotherapy
01/2019 - 02/2008
4Percutaneous Coronary Intervention
06/2013 - 05/2007
4Drug Therapy (Chemotherapy)
10/2009 - 03/2005
3Lymph Node Excision (Lymph Node Dissection)
01/2019 - 05/2007
3Conservative Treatment
11/2016 - 02/2011
3Decompression
11/2016 - 02/2011
3Neoadjuvant Therapy
01/2010 - 03/2005
2Personal Protective Equipment
07/2022 - 01/2021
2Length of Stay
01/2019 - 05/2012
2Mediterranean Diet
01/2018 - 07/2012
2Proctectomy
03/2015 - 03/2007
1Secondary Prevention
08/2023
1Medication Errors (Medication Error)
01/2023
1Vocational Rehabilitation
06/2022
1Colonic Pouches (S Pouch)
11/2020